Dana-farber Cancer Institute

This study tested a combination of two immunotherapy drugs, durvalumab and tremelimumab, in people with malignant pleural mesothelioma, a rare cancer of the lung lining. The trial included 19 participants whose cancer had worsened after standard chemotherapy. The goal was to see …

This study tested a drug called abemaciclib in people with a specific type of advanced breast cancer (triple negative, retinoblastoma-positive) that had spread. The goal was to see if the drug could shrink tumors. The study was stopped early after enrolling 27 participants, so re…

This study tested a new drug, GDC-0084, combined with the standard drug trastuzumab (Herceptin) in 17 people with HER2-positive breast cancer that had spread to the brain. The goal was to see if the combination could shrink or control brain tumors. The trial was terminated early,…